ArticleJournal of immunology research2022

Jujuboside B Reverse CUMS-Promoted Tumor Progression via Blocking PI3K/Akt and MAPK/ERK and Dephosphorylating CREB Signaling.

Zhen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.